6.
    发明专利
    未知

    公开(公告)号:DE3866686D1

    公开(公告)日:1992-01-16

    申请号:DE3866686

    申请日:1988-12-15

    Applicant: BASF AG

    Abstract: Polysulphated heparins (I) are used to prepare medicaments for prophylaxis and therapy of diseases caused by retroviruses. (I) have an S content of 13-15% and a molecular wt. of 2000-20,000 (esp. 2000-9000 for oral admin). They may be prepd. by converting heparin to the pyridinium salt and reacting this with ClSO3H in pyridine. The medicaments may be formulated for oral or parenteral admin., or as sprays. The daily dose is 10-1000 mg/kg oral or 0.1-10 mg/kg parenteral.

Patent Agency Ranking